AAAAAA

   
Results: 1-8 |
Results: 8
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING STUDY OF ORG-2766 IN THE PREVENTION OR DELAY OF CISPLATIN-INDUCEDNEUROPATHIES IN WOMEN WITH OVARIAN-CANCER
Authors: ROBERTS JA JENISON EL KIM KM CLARKEPEARSON D LANGLEBEN A
Citation: Ja. Roberts et al., A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING STUDY OF ORG-2766 IN THE PREVENTION OR DELAY OF CISPLATIN-INDUCEDNEUROPATHIES IN WOMEN WITH OVARIAN-CANCER, Gynecologic oncology, 67(2), 1997, pp. 172-177
A PHASE I II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, CISPLATIN, AND THIOTEPA FOLLOWED BY AUTOLOGOUS BONE-MARROW AND GRANULOCYTE-COLONY-STIMULATING FACTOR-PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH ADVANCED MALIGNANCIES/
Authors: HUSSEIN AM PETROS WP ROSS M VREDENBURGH JJ AFFRONTI ML JONES RB SHPALL EJ RUBIN P ELKORDY M GILBERT C GUPTON C EGORIN MJ SOPER J BERCHUCK A CLARKEPEARSON D BERRY DA PETERS WP
Citation: Am. Hussein et al., A PHASE I II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, CISPLATIN, AND THIOTEPA FOLLOWED BY AUTOLOGOUS BONE-MARROW AND GRANULOCYTE-COLONY-STIMULATING FACTOR-PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH ADVANCED MALIGNANCIES/, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 561-568
PREOPERATIVE EVALUATION OF MACROPHAGE-COLONY-STIMULATING FACTOR LEVELS IN PATIENTS WITH ENDOMETRIAL CANCER
Authors: OLT G SOPER J RAMAKRISHNAN S XU FJ BERCHUCK A CLARKEPEARSON D DODGE R BAST RC
Citation: G. Olt et al., PREOPERATIVE EVALUATION OF MACROPHAGE-COLONY-STIMULATING FACTOR LEVELS IN PATIENTS WITH ENDOMETRIAL CANCER, American journal of obstetrics and gynecology, 174(4), 1996, pp. 1316-1319
DOES AGGRESSIVE THERAPY IMPROVE SURVIVAL IN SUBOPTIMAL STAGE-IIIC-IV OVARIAN-CANCER - A CANADIAN-AMERICAN COMPARATIVE-STUDY
Authors: LOCOCO S COVENS A CARNEY M FRANSSEN E DOGDE R ROSEN B OSBORNE R KERR I BUCKMAN R SOPER J RODRIGUEZ G DEPETRILLO A CLARKEPEARSON D BERCHUCK A
Citation: S. Lococo et al., DOES AGGRESSIVE THERAPY IMPROVE SURVIVAL IN SUBOPTIMAL STAGE-IIIC-IV OVARIAN-CANCER - A CANADIAN-AMERICAN COMPARATIVE-STUDY, Gynecologic oncology, 59(2), 1995, pp. 194-199
A PHASE-I STUDY OF INTRAPERITONEAL INTERFERON-ALPHA(2B) AND INTRAVENOUS CISPLATINUM PLUS CYCLOPHOSPHAMIDE CHEMOTHERAPY IN PATIENTS WITH UNTREATED STAGE-III EPITHELIAL OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP PILOT-STUDY
Authors: MOORE DH VALEA F WALTON LA SOPER J CLARKEPEARSON D FOWLER WC
Citation: Dh. Moore et al., A PHASE-I STUDY OF INTRAPERITONEAL INTERFERON-ALPHA(2B) AND INTRAVENOUS CISPLATINUM PLUS CYCLOPHOSPHAMIDE CHEMOTHERAPY IN PATIENTS WITH UNTREATED STAGE-III EPITHELIAL OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP PILOT-STUDY, Gynecologic oncology, 59(2), 1995, pp. 267-272
VILLOGLANDULAR ADENOCARCINOMA OF THE CERVIX - A CASE-REPORT
Authors: HURTEAU JA RODRIGUEZ GC KAY HH BENTLEY RC CLARKEPEARSON D
Citation: Ja. Hurteau et al., VILLOGLANDULAR ADENOCARCINOMA OF THE CERVIX - A CASE-REPORT, Obstetrics and gynecology, 85(5), 1995, pp. 906-908
INTRAPERITONEAL CISPLATIN AND REGIONAL HYPERTHERMIA FOR OVARIAN-CARCINOMA
Authors: LEOPOLD KA OLESON JR CLARKEPEARSON D SOPER J BERCHUCK A SAMULSKI TV PAGE RL BLIVIN J TOMBERLIN JK DEWHIRST MW
Citation: Ka. Leopold et al., INTRAPERITONEAL CISPLATIN AND REGIONAL HYPERTHERMIA FOR OVARIAN-CARCINOMA, International journal of radiation oncology, biology, physics, 27(5), 1993, pp. 1245-1251
A GYNECOLOGIC-ONCOLOGY-GROUP PHASE-II STUDY OF AMONAFIDE (NSC-308847)IN EPITHELIAL OVARIAN-CANCER
Authors: ASBURY RF BLESSING JA LOOK KY CLARKEPEARSON D HOMESLEY HD
Citation: Rf. Asbury et al., A GYNECOLOGIC-ONCOLOGY-GROUP PHASE-II STUDY OF AMONAFIDE (NSC-308847)IN EPITHELIAL OVARIAN-CANCER, American journal of clinical oncology, 16(6), 1993, pp. 529-531
Risultati: 1-8 |